Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
Smad proteins are critical intracellular mediators of signaling by growth and differentiation factors of the transforming growth factor beta superfamily. We have isolated a member of the Smad family, Smad8, from a rat brain cDNA library and biochemically and functionally characterized its ability to transduce signals from serine kinase receptors. In Xenopus embryo, Smad8 is able to transcriptionally activate a subset of mesoderm target genes similar to those induced by the receptor serine kinase, activin receptor-like kinase (ALK)-2. Smad8 can be specifically phosphorylated by a constitutively active ALK-2 but not the related receptor serine kinase, ALK-4. In response to signaling from ALK-2, Smad8 associates with a common regulatory molecule, Smad4, and this association leads to a synergistic effect on gene transcription. Furthermore, Smad8 is able to rescue the expression of mesoderm genes blocked by truncated ALK-2 in the embryo. These results indicate that Smad8 can function as a downstream signaling mediator of ALK-2.
Figure 1
Smad8 activates Xbra in animal pole explants. (A) Phylogenetic tree of the Smad proteins. The numbers below the tree indicate the percent divergence among the amino acid sequences. The sequences used here include rat Smad1, Smad3, and Smad8, mouse Smad2 and Smad5, human Smad4, Smad6, and Smad7, Drosophila Mad and three Caenorhabditis elegans Mads, sma-2, sma-3 and sma-4. (B) Smad8 induces Xbra in animal pole explants. Xenopus embryos at two-cell stage were injected with 1â2 ng RNA of Smad2, Smad3, Smad5, Smad8 and 10â20 pg of CA ALK-2 or CA ALK-4. The embryos were dissected at stage 9, and the explants were cultured until stage 12. The animal pole explants were analyzed by RNase protection with probes of Xbra, gsc, and EF-1α. The ubiquitously expressed EF-1α was used as a loading control to monitor the total RNA levels among samples. Embryos at stage 12 and the animal pole explants from the uninjected embryos were used as controls. (C) Smad8 synergizes with Smad4 in Xbra activation. Xenopus embryos at two-cell stage were injected with 50 pg of CA ALK2 RNA or 0.2 ng RNA of Smad8 alone, Smad4 alone, or Smad8 together with Smad4. The embryos were dissected at stage 9 and the explants were cultured until stage 12. The animal pole explants were analyzed by RNase protection with probes of Xbra and EF-1α.
Figure 2
CA ALK-2 induces association of Smad8 with Smad4. CHO cells were transiently transfected with control vector (pcDNA3), a Flag-tagged Smad4 (Flag/Smad4) alone, a myc-tagged Smad8 (myc/Smad8) alone, myc/Smad8 and Flag/Smad4, or myc/Smad8 and Flag/Smad4 with CA ALK-2 or CA ALK-4. The transfected cells were lysed, and myc/Smad8 was purified by immunoprecipitation with an anti-myc antibody. The immunoprecipitate was separated on SDS/PAGE, and Flag/Smad4 that complexed with Smad8 was detected by an anti-Flag antibody. The crude cell lysate (1/30th equivalent of the amount used in immunoprecipitation) from above transfection also were separated on SDS/PAGE and detected with anti-Flag or anti-myc antibody to determine the protein expression level of Flag/Smad4 and myc/Smad8.
Figure 3
CA ALK-2 specifically phosphorylates Smad8. (A) CA ALK-2 but not CA ALK-4 phosphorylates Smad8. CHO cells were transiently transfected with control vector (pcDNA3), myc/Smad8, or myc/Smad8 with either CA ALK-2 or CA ALK-4. The transfected cells were labeled with [32P]phosphorus for 3 h before harvesting. The cell lysate was immunoprecipitated with an anti-myc antibody, separated on SDS/PAGE, and detected by autoradiography. The migration of myc/Smad8 on the gel was determined by anti-myc Western blot analysis with the lysate from 32P-unlabeled cells that expressed myc/Smad8 (data not shown). (B) CA ALK-4 but not CA ALK-2 phosphorylates Smad2. 293 cells were transiently transfected with control vector (pcDNA3), a HA-tagged Smad2 (HA/Smad2), and HA/Smad2 with either CA ALK-4 or CA ALK-2. The transfected cells were labeled with [32P]phosphorus, and the cell lysate was immunoprecipitated with an anti-HA antibody followed by separation on SDS/PAGE. The phosphorylation products were detected by autoradiography.
Figure 4
Truncated ALK-2 blocks a subset of mesoderm genes in Xenopus embryo. Albino embryos were injected with ÎALK-2 RNA and a lacZ transcript in the marginal zone at the four-cell stage without dorsal/ventral bias. The lacZ transcript was used in all injections to indicate the distribution of the injected truncated receptor. Embryos were cultured until the 10.5 stage and used in whole-mount in situ hybridization with probes of gsc, Xlim-1, chd, Xbra, and Xnot. Representative embryos are shown here (vegetal view with dorsal side up). (1) gsc expression in uninjected embryos. (2) gsc expression in ÎALK-2 injected embryos. (3) Xlim-1 expression in uninjected embryos. (4) Xlim-1 expression in ÎALK-2 injected embryos. (5) chd expression in uninjected embryos. (6) chd expression in ÎALK-2 injected embryos. (7) Xbra expression in uninjected embryos. (8) Xbra expression in ÎALK-2 injected embryos. (9) Xnot expression in uninjected embryos. (10) Xnot expression in ÎALK-2 injected embryos.
Figure 5
Smad8 rescues the block of Xnot by truncated ALK-2. Albino embryos at the four-cell stage were injected in the marginal zone with in vitro transcribed RNA of ÎALK-2 alone or ÎALK-2 with either Smad2 or Smad8. The embryos were cultured until stage 10.5 and used in whole-mount in situ hybridization with a Xnot probe. The lacZ transcripts was used to indicate the distribution of the injected RNA. Representative embryos are shown (vegetal view with dorsal side up).
Attisano,
TGF-beta receptors and actions.
1994, Pubmed
Attisano,
TGF-beta receptors and actions.
1994,
Pubmed
Attisano,
Activation of signalling by the activin receptor complex.
1996,
Pubmed
Baker,
A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway.
1996,
Pubmed
,
Xenbase
Bhushan,
The transforming growth factor beta type II receptor can replace the activin type II receptor in inducing mesoderm.
1994,
Pubmed
,
Xenbase
Cárcamo,
Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
1994,
Pubmed
Chen,
Regulation of transforming growth factor beta- and activin-induced transcription by mammalian Mad proteins.
1996,
Pubmed
,
Xenbase
Cho,
Molecular nature of Spemann's organizer: the role of the Xenopus homeobox gene goosecoid.
1991,
Pubmed
,
Xenbase
Conlon,
Inhibition of Xbra transcription activation causes defects in mesodermal patterning and reveals autoregulation of Xbra in dorsal mesoderm.
1996,
Pubmed
,
Xenbase
Ebner,
Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.
1993,
Pubmed
Eppert,
MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma.
1996,
Pubmed
,
Xenbase
Gont,
Overexpression of the homeobox gene Xnot-2 leads to notochord formation in Xenopus.
1996,
Pubmed
,
Xenbase
Graff,
Xenopus Mad proteins transduce distinct subsets of signals for the TGF beta superfamily.
1996,
Pubmed
,
Xenbase
Graff,
Studies with a Xenopus BMP receptor suggest that ventral mesoderm-inducing signals override dorsal signals in vivo.
1994,
Pubmed
,
Xenbase
Hahn,
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1.
1996,
Pubmed
Hayashi,
The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling.
1997,
Pubmed
Hoodless,
MADR1, a MAD-related protein that functions in BMP2 signaling pathways.
1996,
Pubmed
Kozak,
Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.
1986,
Pubmed
Kretzschmar,
The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase.
1997,
Pubmed
Lagna,
Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.
1996,
Pubmed
,
Xenbase
Lin,
Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase.
1992,
Pubmed
Liu,
A human Mad protein acting as a BMP-regulated transcriptional activator.
1996,
Pubmed
,
Xenbase
Macías-Silva,
MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling.
1996,
Pubmed
Maéno,
A truncated bone morphogenetic protein 4 receptor alters the fate of ventral mesoderm to dorsal mesoderm: roles of animal pole tissue in the development of ventral mesoderm.
1994,
Pubmed
,
Xenbase
Massaous,
TGF-beta signalling through the Smad pathway.
1997,
Pubmed
Mathews,
Expression cloning of an activin receptor, a predicted transmembrane serine kinase.
1991,
Pubmed
Sasai,
Xenopus chordin: a novel dorsalizing factor activated by organizer-specific homeobox genes.
1994,
Pubmed
,
Xenbase
Smith,
Mesoderm-inducing factors and mesodermal patterning.
1995,
Pubmed
,
Xenbase
Smith,
Expression of a Xenopus homolog of Brachyury (T) is an immediate-early response to mesoderm induction.
1991,
Pubmed
,
Xenbase
Suzuki,
Smad5 induces ventral fates in Xenopus embryo.
1997,
Pubmed
,
Xenbase
Suzuki,
A truncated bone morphogenetic protein receptor affects dorsal-ventral patterning in the early Xenopus embryo.
1994,
Pubmed
,
Xenbase
Talbot,
A homeobox gene essential for zebrafish notochord development.
1995,
Pubmed
,
Xenbase
ten Dijke,
Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.
1994,
Pubmed
ten Dijke,
Characterization of type I receptors for transforming growth factor-beta and activin.
1994,
Pubmed
Tsuchida,
Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor.
1993,
Pubmed
von Dassow,
Induction of the Xenopus organizer: expression and regulation of Xnot, a novel FGF and activin-regulated homeo box gene.
1993,
Pubmed
,
Xenbase
Watanabe,
Cloning and characterization of a novel member of the human Mad gene family (MADH6).
1997,
Pubmed
Wieser,
GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex.
1995,
Pubmed
Wilkinson,
Expression pattern of the mouse T gene and its role in mesoderm formation.
1990,
Pubmed
,
Xenbase
Zhang,
The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
1997,
Pubmed
,
Xenbase
Zhang,
Receptor-associated Mad homologues synergize as effectors of the TGF-beta response.
1996,
Pubmed